These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11391724)

  • 101. Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: case report and review of the literature.
    Tsoussis S; Ekonomidou F; Vourliotaki E; Karalis I; Dermitzakis A
    Am J Hematol; 2004 Aug; 76(4):353-9. PubMed ID: 15282668
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy.
    Decaudin D; Des Guetz G; Mathiot C; Dumont J; Hubert P; Vincent-Salomon A; Pouillart P
    Ann Oncol; 2003 Jan; 14(1):171-2. PubMed ID: 12488313
    [No Abstract]   [Full Text] [Related]  

  • 103. Use of rituximab in chronic childhood immune thrombocytopenic purpura.
    Bay A; Oner AF; Uner A; Dogan M
    Pediatr Int; 2006 Oct; 48(5):514-6. PubMed ID: 16970796
    [No Abstract]   [Full Text] [Related]  

  • 104. Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphoma.
    van de Loosdrecht AA; Huijgens PC; Ossenkoppele GJ
    Curr Opin Hematol; 2004 Nov; 11(6):419-25. PubMed ID: 15548997
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Passive immunotherapy with monoclonal antibodies].
    Bokemeyer C; Panse J
    Onkologie; 2005 Oct; 28 Suppl 4():9-13. PubMed ID: 16205099
    [No Abstract]   [Full Text] [Related]  

  • 106. The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.
    Ahmadzadeh V; Tofigh R; Farajnia S; Pouladi N
    Int Rev Immunol; 2016; 35(2):136-55. PubMed ID: 26325124
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Treatment of idiopathic thrombocytopenic purpura in adults].
    Glud TK; Rosthøj S; Jensen MK
    Ugeskr Laeger; 1983 Jun; 145(25):1931-3. PubMed ID: 6684339
    [No Abstract]   [Full Text] [Related]  

  • 108. [Primary immune thrombocytopenia].
    Wehrli M; Goede JS
    Praxis (Bern 1994); 2014 Apr; 103(9):485-94; quiz 495-6. PubMed ID: 24755495
    [No Abstract]   [Full Text] [Related]  

  • 109. Primary lymphoma of the lung: a report of two cases.
    Rastogi N; Hukku S; Ayyagari S
    Indian J Chest Dis Allied Sci; 1996; 38(2):123-8. PubMed ID: 8822647
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation.
    Gergis U; Ibrahim M; Al-Kazaz M; Parkash S; Gergis E; Desancho M
    J Clin Oncol; 2012 Sep; 30(26):e241-2. PubMed ID: 22649137
    [No Abstract]   [Full Text] [Related]  

  • 111. Idiopathic Thrombocytopenic Purpura in Individuals Older than 75 Years: A Rare Series.
    Zulfiqar AA
    South Med J; 2017 Sep; 110(9):603. PubMed ID: 28863226
    [No Abstract]   [Full Text] [Related]  

  • 112. Rituxan in the treatment of cold agglutinin disease.
    Lee EJ; Kueck B
    Blood; 1998 Nov; 92(9):3490-1. PubMed ID: 9787200
    [No Abstract]   [Full Text] [Related]  

  • 113. Vaccine therapies for non-Hodgkin's lymphoma.
    Timmerman JM
    Curr Treat Options Oncol; 2002 Aug; 3(4):307-15. PubMed ID: 12074767
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Treatment of malignant low-grade lymphoma. Follicular Lymphoma Study Group].
    Solal-Celigny P
    Rev Med Interne; 1998; 19 Suppl 1():18S-20S. PubMed ID: 9789523
    [No Abstract]   [Full Text] [Related]  

  • 115. [Low thrombocyte count: when does it become dangerous?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Oct; 153(42):20-1. PubMed ID: 22053439
    [No Abstract]   [Full Text] [Related]  

  • 116. [Corticosteroid resistant idiopathic thrombocytopenic purpura].
    Murai K; Kuriya S
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):299-302. PubMed ID: 9833495
    [No Abstract]   [Full Text] [Related]  

  • 117. Crohn's colitis and idiopathic thrombocytopenic purpura.
    Boyne MS; Dye KR
    Postgrad Med J; 2000 May; 76(895):299-300. PubMed ID: 10775285
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Immunotherapy: a novel treatment for Non-Hodgkin's lymphoma.
    Hohenstein M
    Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):10-5. PubMed ID: 11878046
    [TBL] [Abstract][Full Text] [Related]  

  • 119. A case of pregnancy complicated by non-Hodgkin's lymphoma and idiopathic thrombocytopenic purpura.
    Wang JL; Zhao YY; Jiang YH
    Chin Med J (Engl); 2013 Mar; 126(5):948. PubMed ID: 23489807
    [No Abstract]   [Full Text] [Related]  

  • 120. Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab.
    Lin CY; Chen HC; Hwang WL; Teng CL
    Ann Hematol; 2011 Jun; 90(6):731-2. PubMed ID: 20852997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.